Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infectious Encephalitis”

238 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 238 results

Not applicableStudy completedNCT00000674
What this trial is testing

A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS

Who this might be right for
Toxoplasmosis, CerebralHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableActive Not RecruitingNCT07145502
What this trial is testing

Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes

Who this might be right for
Autoimmune EncephalitisEarly-stage PanencephalitisNeuroinflammatory Demyelination
Biocells Medical 76
Large-scale testing (Phase 3)Study completedNCT01386827
What this trial is testing

Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis

Who this might be right for
Japanese Encephalitis
Helsinki University Central Hospital 120
Very early researchStudy completedNCT04781309
What this trial is testing

NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal Leukoencephalopathy

Who this might be right for
Progressive Multifocal Leukoencephalopathy
National Institute of Neurological Disorders and Stroke (NINDS) 12
Large-scale testing (Phase 3)Study completedNCT00595270
What this trial is testing

Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 349
Post-approval studies (Phase 4)Study completedNCT00161967
What this trial is testing

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 375
Not applicableStudy completedNCT04687332
What this trial is testing

IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases

Who this might be right for
Neurological Autoimmune Diseases
University Medical Center Mainz 32
Post-approval studies (Phase 4)Looking for participantsNCT06151392
What this trial is testing

Effect of Probiotic and Zinc Supplementations on the Clinical Outcome in Pediatric Patients with Ventriculitis

Who this might be right for
Ventriculitis, Infectious
Ain Shams University 140
Large-scale testing (Phase 3)Not Yet RecruitingNCT06276504
What this trial is testing

Pembrolizumab in Progressive Multifocal Leukoencephalopathy (PML) in Immunocompromised Patients Without HIV Infection

Who this might be right for
Progressive Multifocal Leukoencephalopathy
Assistance Publique - Hôpitaux de Paris 33
Not applicableStudy completedNCT03969550
What this trial is testing

Do CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoencephalopathy?

Who this might be right for
AIDSProgressive Multifocal Leucoencephalopathy (PML)
Fondation Ophtalmologique Adolphe de Rothschild 34
Large-scale testing (Phase 3)Study completedNCT00161876
What this trial is testing

FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 3,973
Testing effectiveness (Phase 2)Study completedNCT00161850
What this trial is testing

FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 615
Post-approval studies (Phase 4)Study completedNCT00463684
What this trial is testing

Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age

Who this might be right for
Japanese Encephalitis
PATH 278
Not applicableStudy completedNCT04453917
What this trial is testing

Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy

Who this might be right for
Progressive Multifocal Leukoencephalopathy
University Hospital, Toulouse 22
Post-approval studies (Phase 4)Study completedNCT02880865
What this trial is testing

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

Who this might be right for
Encephalitis, JapaneseMeaslesMumps+1 more
PATH 628
Testing effectiveness (Phase 2)Study completedNCT00442169
What this trial is testing

Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults

Who this might be right for
West Nile Fever
Sanofi Pasteur, a Sanofi Company 208
Large-scale testing (Phase 3)Study completedNCT01408537
What this trial is testing

Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children

Who this might be right for
Encephalitis, Japanese B
Mahidol University 152
Not applicableLooking for participantsNCT06502015
What this trial is testing

Biomarkers in Autoimmune Disease of Nervous System

Who this might be right for
Autoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum DisorderMultiple Sclerosis+8 more
Tongji Hospital 50,000
Large-scale testing (Phase 3)Study completedNCT01900444
What this trial is testing

Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 119
Post-approval studies (Phase 4)UnknownNCT04817917
What this trial is testing

Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province

Who this might be right for
Japanese EncephalitisVaccine Preventable DiseaseVaccine Reaction
Zhejiang Provincial Center for Disease Control and Prevention 712
Next Page